Recent MD Labs Ruling Has Implications for Test Requisitions and Commissions
A federal appeals court upheld the idea that clinical laboratories can rely on physician orders to justify medical necessity
A federal appeals court upheld the idea that clinical laboratories can rely on physician orders to justify medical necessity
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Other recent legal actions include a self-disclosure settlement and punishment for alleged improper diagnostic test add-ons
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Recent case shows why failing to disclose to individuals the lab test list prices they may need to pay doesn’t count as consumer fraud.
Sentencing has been postponed for one month to explore possible government mishandling of key witness testimony.
Federal San Jose jury finds ex-Theranos COO guilty of all 10 ten counts of wire fraud and two counts of conspiracy to commit wire fraud.
Caris Life Sciences agrees to pay $2.8 million to settle claims that it purposely delayed submitting lab tests to get around Medicare’s 14-day rule.
Company involved in recent Class 1 recalls of COVID-19 rapid tests now faces further fallout by not refunding customers for faulty tests.
amesh “Sunny” Balwani’s legal team makes the case that Holmes is solely responsible for Theranos misdoings.
A new case from the US Court of Appeals for the Ninth Circuit tests how far the public disclosure bar goes.